Sign up to save your podcasts
Or
Share Biologics in COPD: Why, when and who
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Biologics in COPD: Why, when and who
Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients.
Send us a text
Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA
Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
Follow us on:
- Instagram @pulmapps
- Twitter@pulmapp
- Facebook @association of pulmonary advance practice providers.
View all episodes
By APAPP
5
55 ratings
Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients.
Send us a text
Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA
Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
Follow us on:
- Instagram @pulmapps
- Twitter@pulmapp
- Facebook @association of pulmonary advance practice providers.
More shows like The APAPP Podcast
View all
Mayo Clinic Talks
288 Listeners
The Curbsiders Internal Medicine Podcast
3,342 Listeners
Up First from NPR
56,391 Listeners
Core IM | Internal Medicine Podcast
1,155 Listeners
Run the List
248 Listeners
Pharmacy to Dose: The Critical Care Podcast
159 Listeners
Lungcast
15 Listeners
Giggly Squad
14,969 Listeners